Vir Biotechnology to Participate in Upcoming Investor Healthcare Conferences
29. August 2023 16:30 ET
|
Vir Biotechnology, Inc.
SAN FRANCISCO, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that management will be participating in the following upcoming investor conferences during the...
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2023 Financial Results
03. August 2023 16:05 ET
|
Vir Biotechnology, Inc.
– Phase 2 data readouts from ongoing chronic hepatitis B and chronic hepatitis delta programs on track for Q4 2023 – – Increased focus on proprietary antibody platform and discontinuation of...
Vir Biotechnology Announces Topline Data from Phase 2 PENINSULA Trial Evaluating VIR-2482 for the Prevention of Seasonal Influenza A Illness
20. Juli 2023 08:00 ET
|
Vir Biotechnology, Inc.
SAN FRANCISCO, July 20, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the Phase 2 PENINSULA (PrevEntioN of IllNesS DUe to InfLuenza A) trial evaluating VIR-2482...
Vir Biotechnology to Participate in the 44th Annual Goldman Sachs Global Healthcare Conference
05. Juni 2023 16:05 ET
|
Vir Biotechnology, Inc.
SAN FRANCISCO, June 05, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer, is scheduled to...
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2023 Financial Results
04. Mai 2023 16:05 ET
|
Vir Biotechnology, Inc.
– Multiple data readouts anticipated in 2023 from ongoing Phase 2 programsin hepatitis B and D, and influenza – – Industry veteran Dr. Marianne De Backer assumes CEO position prepared to lead Company...
Vir Biotechnology to Participate in the BofA Securities 2023 Health Care Conference
03. Mai 2023 16:05 ET
|
Vir Biotechnology, Inc.
SAN FRANCISCO, May 03, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer, is scheduled to present at...